Literature DB >> 7974534

Incidence of transcranial Doppler-detected cerebral microemboli in patients referred for echocardiography.

D C Tong1, A Bolger, G W Albers.   

Abstract

BACKGROUND AND
PURPOSE: Transcranial Doppler can detect cerebral microemboli. These emboli may be a risk factor for embolic stroke. We studied the prevalence of microemboli in patients referred for echocardiography.
METHODS: Forty-two patients were evaluated. Patients were studied with continuous monitoring over one middle cerebral artery for 30 minutes, and the number of microemboli was recorded. Patients were divided into three groups, those with prosthetic heart valves (group A, n = 15), atrial fibrillation (group B, n = 14), and no major cardiac risk factor (group C, n = 14).
RESULTS: Seventeen percent (7 of 42) of all patients had microemboli. In group A, 5 of 15 (33%) had microemboli. In group B, 2 of 13 (15%) patients had microemboli. Twenty-five percent (7 of 28) of patients in groups A and B combined (A+B) had microemboli. No patients (0 of 14) in group C had microemboli. Groups A and A+B had significantly more emboli than group C (P < .05). Prosthetic heart valve patients with emboli more commonly had a history of prior stroke than valve patients without emboli (3 of 5 versus 2 of 10). The number of emboli seen per 30-minute monitoring session was greater in patients with a prior history of stroke than in patients without (10 microemboli versus 3).
CONCLUSIONS: Microemboli can be found in a significant percentage of selected patients referred for echocardiography. The prevalence of microembolism is greater in patients with a known high risk of embolization (eg, prosthetic valves) and less in patients with a lower risk of embolization (eg, atrial fibrillation). These microemboli may be associated with an increased prevalence of previous stroke in patients with prosthetic valves.

Entities:  

Mesh:

Year:  1994        PMID: 7974534     DOI: 10.1161/01.str.25.11.2138

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  8 in total

Review 1.  Prevention of cardioembolic stroke.

Authors:  William David Freeman; Maria I Aguilar
Journal:  Neurotherapeutics       Date:  2011-07       Impact factor: 7.620

2.  Microembolic signals and diffusion-weighted MR imaging abnormalities in acute ischemic stroke.

Authors:  K Kimura; K Minematsu; M Koga; R Arakawa; M Yasaka; H Yamagami; K Nagatsuka; H Naritomi; T Yamaguchi
Journal:  AJNR Am J Neuroradiol       Date:  2001 Jun-Jul       Impact factor: 3.825

3.  Carotid atherosclerotic plaque instability and cognition determined by ultrasound-measured plaque strain in asymptomatic patients with significant stenosis.

Authors:  Robert J Dempsey; Tomy Varghese; Daren C Jackson; Xiao Wang; Nirvedh H Meshram; Carol C Mitchell; Bruce P Hermann; Sterling C Johnson; Sara E Berman; Stephanie M Wilbrand
Journal:  J Neurosurg       Date:  2017-03-10       Impact factor: 5.115

4.  Microembolic signals in patients undergoing coronary artery bypass grafting. Effect of aortic atherosclerosis.

Authors:  E Kumral; K Balkir; T Yağdi; E Kara; D Evyapan; O Bilkay
Journal:  Tex Heart Inst J       Date:  2001

Review 5.  Cardioembolic stroke: An update on etiology, diagnosis and management.

Authors:  Megan C Leary; Louis R Caplan
Journal:  Ann Indian Acad Neurol       Date:  2008-01       Impact factor: 1.714

Review 6.  Heart diseases and stroke.

Authors:  Cathy A Sila
Journal:  Curr Neurol Neurosci Rep       Date:  2006-01       Impact factor: 5.081

7.  Atrial fibrillation: villain or bystander in vascular brain injury.

Authors:  Ben Freedman; Hooman Kamel; Isabelle C Van Gelder; Renate B Schnabel
Journal:  Eur Heart J Suppl       Date:  2020-12-06       Impact factor: 1.803

8.  Clinical assessment, neuroimaging and immunomarkers in Chagas disease study (CLINICS): Rationale, study design and preliminary findings.

Authors:  Jamary Oliveira-Filho; Jesângeli de S Dias; Pedro A P Jesus; Nestor J S B Neto; Roque Aras; Francisco J F B Reis; Karen L Furie
Journal:  Dement Neuropsychol       Date:  2012 Jul-Sep
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.